Wolverine Trading, LLC Sangamo Therapeutics, Inc Transaction History

Wolverine Trading, LLC

$97.8 Billion
Q1 2024

A detailed history of Wolverine Trading, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 10,200 shares of SGMO stock, worth $3,264. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,200

Holding current value

$3,264

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $186,668 - $292,526	-17,157 Reduced 58.58%	12,129 $142,000
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $156,919 - $309,078	17,001 Added 138.39%	29,286 $494,000
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $29,575 - $39,349	-3,153 Reduced 20.42%	12,285 $121,000
Q2 2020 Aug 13, 2020	SELL	$6.21 - $11.83 $127,938 - $243,721	-20,602 Reduced 57.16%	15,438 $135,000
Q1 2020 May 11, 2020	SELL	$5.05 - $8.85 $242,793 - $425,490	-48,078 Reduced 57.16%	36,040 $234,000

Q4 2019 Feb 12, 2020	SELL	$8.03 - $11.7 $44,887 - $65,402	-5,590 Reduced 6.23%	84,118 $686,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $99,197 - $133,943	-10,961 Reduced 10.89%	89,708 $824,000
Q2 2019 Aug 20, 2019	SELL	$8.75 - $13.03 $152,503 - $227,099	-17,429 Reduced 14.76%	100,669 $1.08 Million
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $289,654 - $480,631	-37,520 Reduced 24.11%	118,098 $1.13 Million
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $1.31 Million - $2.29 Million	137,927 Added 779.65%	155,618 $1.69 Million
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $584,953 - $853,897	-44,824 Reduced 71.7%	17,691 $300,000
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $227,522 - $340,302	19,614 Added 45.72%	62,515 $1.03 Million
Q3 2017 Nov 15, 2017	BUY	$8.4 - $15.0 $360,368 - $643,515	42,901	42,901 $644,000

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $50.1M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Sangamo Therapeutics, Inc Transaction History